Yin Sun

shenyang pharmaceutical university

H指数:40

被引数:5,547

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Design, Synthesis, Biological Activity Evaluation, and Molecular Docking of 2-Aminopyrimidine-Based PKMYT1 Inhibitors

基于2-氨基嘧啶的PKMYT1抑制剂的分子设计、合成、生物活性评价及分子对接

Biomedicines

IF3.9

2026-08-290

Design, Synthesis, and Biological Activity Evaluation of Quinazoline-Based PLK4 Inhibitors

基于喹唑啉的PLK4抑制剂的分子设计、合成与生物活性评价

Biomedicines

IF3.9

2026-08-130

Design, Synthesis, and Computational Insights into PKMYT1 Inhibitors for the Treatment of Breast Cancer

设计、合成及对乳腺癌治疗用PKMYT1抑制剂的计算洞察

Biomedicines

IF3.9

2026-03-030

OAAI

Phosphorus application enhances cadmium tolerance in Salix caprea via physiological and anatomical adjustments

磷素施用通过生理和形态学上的调整增强了Salix caprea对镉的耐受性。

TREE PHYSIOLOGY

IF3.7

2025-11-010

PRE

Enhanced fermentative hydrogen production from high-strength molasses by oyster shell conditioning: Performance and mechanisms

通过牡蛎壳调理强化高浓度糖蜜的发酵产氢：性能与机制

Bioresource Technology

IF9

2025-09-140

PRE

Discovery of potent and selective PKMYT1 inhibitors for the treatment of CCNE1-amplified cancer

发现强效且选择性PKMYT1抑制剂，用于治疗CCNE1扩增型癌症

European Journal of Medicinal Chemistry

IF5.9

2025-08-180

PRE

The Analysis of Emotion-Aware Personalized Recommendations via Multimodal Data Fusion in the Field of Art

JOURNAL OF ORGANIZATIONAL AND END USER COMPUTING

IF3.4

2025-01-230

Comparative Review for Enhancing CO2 Capture Efficiency with Mixed Amine Systems and Catalysts

用混合胺体系和催化剂提高CO2捕集效率的比较综述

MOLECULES

IF4.6

2024-09-291

OAAI

miR-148b-5p regulates hypercalciuria and calcium-containing nephrolithiasis

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2024-08-252

OAAI

Auxin efflux carrier PsPIN4 identified through genome-wide analysis as vital factor of petal abscission

FRONTIERS IN PLANT SCIENCE

IF4.8

2024-05-100

OAAI

Circ-RAPGEF5 promotes intrahepatic cholangiocarcinoma progression by stabilizing SAE1 to facilitate SUMOylation

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2023-09-133

OAAI

Discovery of the First Potent, Selective, and In Vivo Efficacious Polo-like Kinase 4 Proteolysis Targeting Chimera Degrader for the Treatment of TRIM37-Amplified Breast Cancer

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2023-06-0610

PRE

Predictive value of single-nucleotide polymorphism signature for nephrolithiasis recurrence: a 5-year prospective study

CLINICAL KIDNEY JOURNAL

IF4.6

2023-05-250

OAAI

Design, synthesis and biological evaluation of novel indolin-2-one derivatives as potent second-generation TRKs inhibitors

新型indolin-2-one衍生物作为第二代TRKs抑制剂的设计、合成及生物活性评价

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2023-05-015

PRE

Chemical composition and anticonvulsant activities of herb pair of Gastrodia elata Blume-Acorus tatarinowii Schott decoction on experimentally induced seizures in mice

METABOLIC BRAIN DISEASE

IF3.5

2023-04-129

Discovery of CZS-241: A Potent, Selective, and Orally Available Polo-Like Kinase 4 Inhibitor for the Treatment of Chronic Myeloid Leukemia

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2023-02-036

PRE

Eucommia bark/leaf extract improves HFD-induced lipid metabolism disorders via targeting gut microbiota to activate the Fiaf-LPL gut-liver axis and SCFAs-GPR43 gut-fat axis

杜仲皮/叶提取物通过靶向肠道菌群激活fiaf-lpl肠-肝轴和SCFAs-GPR43肠-脂肪轴改善HFD诱导的脂质代谢紊乱

PHYTOMEDICINE

IF8.3

2023-02-0114

OAAI

Design, synthesis, and biological evaluation of novel pyrimidin-2-amine derivatives as potent PLK4 inhibitors

RSC MEDICINAL CHEMISTRY

IF3.6

2023-01-011

PRE

Structure-based discovery of 1-(3-fluoro-5-(5-(3-(methylsulfonyl) phenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)phenyl)-3-(pyrimidin-5-yl)urea as a potent and selective nanomolar type-II PLK4 inhibitor

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2022-12-0110

PRE

Hypoxia increases RCC stem cell phenotype via altering the androgen receptor (AR)-lncTCFL5-2-YBX1-SOX2 signaling axis

CELL AND BIOSCIENCE

IF6.2

2022-11-177

OAAI

Yin Sun

个人简介

教育背景

工作经历

荣誉奖项

研究方向